Literature DB >> 2174301

Histopathologic, immunophenotypic, and genotypic analysis of Ki-1 anaplastic large cell lymphomas that express histiocyte-associated antigens.

A Carbone1, A Gloghini, V De Re, P Tamaro, M Boiocchi, R Volpe.   

Abstract

CD30/Ki-1 antigen expression in 243 cases of malignant lymphomas was examined using Ber-H2 monoclonal antibody. Among them 20 cases were categorized as Ki-1 anaplastic large cell lymphoma. In two of these cases histiocyte-associated markers were also expressed. In these cases histopathologic and extensive in situ immunophenotypic analyses were used with genotypic studies in the determination of cell lineage. A sinusoid histologic pattern of involvement with partial lymph node infiltration by pleomorphic neoplastic cells was noticed in the nodes from both patients. Solid areas of node replacement resembling metastatic carcinoma were seen in Patient 1. Immunohistologically, tumor cells of both cases were positive for CD30, CD25, CD71, LN3 (HLA-DR), EMA, CD45, CD74, vimentin, alpha-1-antichymotrypsin, and CD68. Patient 1 was also CD45RO+, CD43+, whereas Patient 2 was positive for alpha-1-antitrypsin and CD4 tumor cells. Genotypic studies revealed that TCR beta and TCR gamma chain genes were clonally rearranged in Patient 1, whereas no rearrangements were detected in Patient 2. This study supports the view that some Ki-1 anaplastic large cell lymphomas may express multiple histiocyte-associated antigens and confirms that this group of neoplasms have immunophenotypic heterogeneity. The results of genotypic analyses used with immunophenotyping does not exclude that the tumor cells in these cases may be of true histiocytic origin despite the Ki-1-positive phenotype.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2174301     DOI: 10.1002/1097-0142(19901215)66:12<2547::aid-cncr2820661217>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  Paraffin section immunohistochemistry in the diagnosis of Hodgkin's disease and anaplastic large cell (CD30+) lymphomas.

Authors:  A Carbone; A Gloghini; R Volpe
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  Sialosylated Lewis chi expression in CD30-positive anaplastic large-cell lymphomas.

Authors:  K Kasai; Y Sato; S Kuwao; Y Kawakubo; H Inoue; T Kameya
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

Review 3.  Primary platelet-derived growth factor-producing, spindle-shaped diffuse large B-cell lymphoma of the skull: a case report and literature review.

Authors:  Kei-Ji Sugimoto; Asami Shimada; Kunimoto Ichikawa; Mutsumi Wakabayashi; Yasunobu Sekiguchi; Hiroshi Izumi; Yasunori Ota; Norio Komatsu; Masaaki Noguchi
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

4.  Galectin-3, a beta-galactoside-binding animal lectin, is a marker of anaplastic large-cell lymphoma.

Authors:  K N Konstantinov; B A Robbins; F T Liu
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

5.  Co-expression of Epstein-Barr virus latent membrane protein and vimentin in "aggressive" histological subtypes of Hodgkin's disease.

Authors:  A Carbone; A Gloghini; I Zanette; B Canal; A Rizzo; R Volpe
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 6.  T-cell lymphomas, a challenging disease: types, treatments, and future.

Authors:  Helen Ma; Maher Abdul-Hay
Journal:  Int J Clin Oncol       Date:  2016-10-14       Impact factor: 3.402

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.